Ask a Question

User designmeat6

Member for: 1 day (since Jul 9)
Type: Registered user
Full name:
Location:
Website: https://www.selleckchem.com/products/ABT-869.html
About: Profitable treatments for respiratory adenocarcinoma with ALK/EGFR co-alterations and PD-L1 over-expression by bevacizumab coupled with chemotherapy.

Activity by designmeat6

Score: 100 points (ranked #49)
Questions: 0
Answers: 0
Comments: 0
Voted on: 0 questions, 0 answers
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes

Wall for designmeat6

Please log in or register to post on this wall.
Snow Theme by Q2A Market
Powered by Question2Answer
...